Formulation And In Vitro Evaluation Of Floating Drug Delivery System Of Quetiapine Hemifumarate

Authors

  • Karan K. Patil Department of Pharmaceutics, S.M.B.T College of Pharmacy, Dhamangaon, Nashik, Maharastra-India.
  • Deelip V. Derle Department of Pharmaceutics, S.M.B.T College of Pharmacy, Dhamangaon, Nashik, Maharastra-India.
  • Saptarshi Datta Department of Pharmaceutics, S.M.B.T College of Pharmacy, Dhamangaon, Nashik, Maharastra-India.

Keywords:

Gastroretention, Floating drug delivery systems, Quetiapine Hemifumarate, HPMC, In vitro buoyancy, In vitro floating

Abstract

The objective of the present investigation was to design and develop a floating drug delivery system of Quetiapine Hemifumarate using different viscosity grades of hydroxypropylmethylcellulose (HPMC K4M, HPMC K15M and HPMC K100M) in varying ratios to formulate floating tablets by direct compression method. Sodium bicarbonate and citric acid was use in the dosage form as a source of carbon-di-oxide to maintain buoyancy. The tablets were evaluated for thickness, weight variation, hardness, friability, drug content, in vitro buoyancy test, in vitro release characteristics and short term stability studies. The drug release from those tablets was sufficiently sustained (about 12 hr) and non-Fickian transport of the drug from tablets was confirmed. Formulation F1 containing HPMC K4M can be considered as an optimized formulation for gastroretentive floating tablet of Quetiapine Hemifumarate. The results of in vitro release studies showed that optimized formulation F1 could sustain drug release (99.63%) for 12 hours and remain buoyant for more than 12 hours. It was found that among the three viscosity grades i.e. HPMC K4M, HPMC K15M and HPMC K100M, HPMC K4M was found to be beneficial in improving the drug release rate and floating properties.

Downloads

Download data is not yet available.

Published

2013-07-01

How to Cite

Patil, K. K., Derle, D. V., & Datta, S. (2013). Formulation And In Vitro Evaluation Of Floating Drug Delivery System Of Quetiapine Hemifumarate. Asian Journal of Pharmaceutical Research and Development, 1(4), 138–151. Retrieved from https://www.ajprd.com/index.php/journal/article/view/117

Issue

Volume 1st issue 4th July-Aug 2013

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).